Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Post by EbbFlow88on May 20, 2021 10:10am
99 Views
Post# 33237046

Margins

Margins
During the first quarter ended March 31, 2021, revenue increased by 10%, but cost of goods sold increased by 29%. The increase in cost of goods sold was higher than the increase in revenue which has contributed to an overall decrease in the gross margin percentage from 56% to 48%. While the gross margin percentage in the first quarter of 2021 at 48% was lower than the comparative quarter in 2020, it does represent an improvement over the 37% margin experienced in the fourth quarter of 2020 following the integration of two manufacturing sites under one single site.


Margins got squeezed slighly with higher input costs and fine tuning for newer equipment/edmonton plant. However, now we are under one roof. This should normalize over time.
<< Previous
Bullboard Posts
Next >>